John Duan

1.7k total citations
23 papers, 1.2k citations indexed

About

John Duan is a scholar working on Pharmaceutical Science, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, John Duan has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmaceutical Science, 7 papers in Pediatrics, Perinatology and Child Health and 5 papers in Molecular Biology. Recurrent topics in John Duan's work include Drug Solubulity and Delivery Systems (8 papers), Pharmaceutical studies and practices (7 papers) and Pharmacogenetics and Drug Metabolism (5 papers). John Duan is often cited by papers focused on Drug Solubulity and Delivery Systems (8 papers), Pharmaceutical studies and practices (7 papers) and Pharmacogenetics and Drug Metabolism (5 papers). John Duan collaborates with scholars based in United States, Germany and Canada. John Duan's co-authors include Jogarao Gobburu, Kimberly Benson, Richard Pazdur, John R. Johnson, Martin H. Cohen, Mark D. Rothmann, Sung K. Kim, Atiqur Rahman, John K. Leighton and Grant Williams and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Phytochemistry.

In The Last Decade

John Duan

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Duan United States 12 297 272 252 186 184 23 1.2k
Julie Bullock United States 17 515 1.7× 467 1.7× 356 1.4× 95 0.5× 244 1.3× 26 1.6k
Huixin Yu Netherlands 17 334 1.1× 315 1.2× 222 0.9× 255 1.4× 174 0.9× 33 1.1k
Nageshwar Budha United States 22 477 1.6× 478 1.8× 118 0.5× 247 1.3× 117 0.6× 52 1.5k
Balaji Agoram United States 18 306 1.0× 331 1.2× 140 0.6× 52 0.3× 51 0.3× 46 1.3k
Chee M. Ng United States 23 481 1.6× 503 1.8× 47 0.2× 118 0.6× 110 0.6× 57 1.7k
Rajeev Menon United States 24 289 1.0× 307 1.1× 305 1.2× 36 0.2× 285 1.5× 104 1.9k
Akintunde Bello United States 21 891 3.0× 444 1.6× 107 0.4× 582 3.1× 108 0.6× 71 1.7k
E. Brendel Germany 21 818 2.8× 891 3.3× 137 0.5× 558 3.0× 100 0.5× 53 2.1k
Jiang Liu United States 16 446 1.5× 426 1.6× 146 0.6× 149 0.8× 71 0.4× 43 1.5k

Countries citing papers authored by John Duan

Since Specialization
Citations

This map shows the geographic impact of John Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Duan more than expected).

Fields of papers citing papers by John Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Duan. The network helps show where John Duan may publish in the future.

Co-authorship network of co-authors of John Duan

This figure shows the co-authorship network connecting the top 25 collaborators of John Duan. A scholar is included among the top collaborators of John Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Duan. John Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Duan, John. (2020). A Biopharmetrics Approach for Drug Product Quality Control with Clinical Relevance. Journal of Pharmaceutical Sciences. 110(1). 478–488. 4 indexed citations
3.
Zhang, Xinyuan, John Duan, Filippos Kesisoglou, et al.. (2017). Mechanistic Oral Absorption Modeling and Simulation for Formulation Development and Bioequivalence Evaluation: Report of an FDA Public Workshop. CPT Pharmacometrics & Systems Pharmacology. 6(8). 492–495. 38 indexed citations
4.
Suarez‐Sharp, Sandra, Angelica Dorantes, John Duan, et al.. (2016). Regulatory Perspectives on Strength-Dependent Dissolution Profiles and Biowaiver Approaches for Immediate Release (IR) Oral Tablets in New Drug Applications. The AAPS Journal. 18(3). 578–588. 10 indexed citations
5.
Yang, Xiaoxia, John Duan, & Jeffrey W. Fisher. (2016). Application of Physiologically Based Absorption Modeling to Characterize the Pharmacokinetic Profiles of Oral Extended Release Methylphenidate Products in Adults. PLoS ONE. 11(10). e0164641–e0164641. 11 indexed citations
6.
Suarez‐Sharp, Sandra, et al.. (2016). Regulatory Experience with In Vivo In Vitro Correlations (IVIVC) in New Drug Applications. The AAPS Journal. 18(6). 1379–1390. 67 indexed citations
7.
Duan, John, et al.. (2016). Scientific and Regulatory Considerations in Solid Oral Modified Release Drug Product Development. The AAPS Journal. 18(6). 1406–1417. 9 indexed citations
8.
Kaur, Paramjeet, et al.. (2015). Applications of In Vitro–In Vivo Correlations in Generic Drug Development: Case Studies. The AAPS Journal. 17(4). 1035–1039. 32 indexed citations
9.
Qiu, Yihong, et al.. (2013). Influence of Drug Property and Product Design on In Vitro–In Vivo Correlation of Complex Modified-Release Dosage Forms. Journal of Pharmaceutical Sciences. 103(2). 507–516. 3 indexed citations
10.
11.
Duan, John, André J. Jackson, & Ping Zhao. (2010). Bioavailability Considerations in Evaluating Drug‐Drug Interactions Using the Population Pharmacokinetic Approach. The Journal of Clinical Pharmacology. 51(7). 1087–1100. 8 indexed citations
12.
Duan, John. (2010). Drug-Drug Interaction Pattern Recognition. Drugs in R&D. 10(1). 9–24. 11 indexed citations
13.
Mahmood, Iftekhar & John Duan. (2009). Population Pharmacokinetics with a Very Small Sample Size. Drug metabolism and drug interactions. 24(2-4). 259–274. 21 indexed citations
14.
Duan, John. (2009). Two Commonly Used Methods for Exposure—Adverse Events Analysis: Comparisons and Evaluations. The Journal of Clinical Pharmacology. 49(5). 540–552. 4 indexed citations
15.
Bhattaram, Venkatesh Atul, Charles R. Bonapace, John Duan, et al.. (2007). Impact of Pharmacometric Reviews on New Drug Approval and Labeling Decisions—a Survey of 31 New Drug Applications Submitted Between 2005 and 2006. Clinical Pharmacology & Therapeutics. 81(2). 213–221. 85 indexed citations
16.
Duan, John. (2007). Applications of population pharmacokinetics in current drug labelling. Journal of Clinical Pharmacy and Therapeutics. 32(1). 57–79. 24 indexed citations
17.
Bhattaram, Venkatesh Atul, Brian Booth, B. Nhi Beasley, et al.. (2005). Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applications. The AAPS Journal. 7(3). E503–E512. 95 indexed citations
18.
Desai, Pankaj B., John Duan, Yaowei Zhu, & Samir A. Kouzi. (1998). Human liver microsomal metabolism of paclitaxel and drug interactions. European Journal of Drug Metabolism and Pharmacokinetics. 23(3). 417–424. 64 indexed citations
19.
Duan, John, et al.. (1997). Reversal of doxorubicin resistance in multidrug resistant melanoma cells in vitro and in vivo by dipyridamole.. PubMed. 19(4). 231–9. 7 indexed citations
20.
Majak, W., et al.. (1994). Alkaloid distribution in two species of Lupinus in central British Columbia. Phytochemistry. 36(4). 883–885. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie Bullock Breakdown of academic impact, for papers by Huixin Yu Breakdown of academic impact, for papers by Nageshwar Budha Breakdown of academic impact, for papers by Balaji Agoram Breakdown of academic impact, for papers by Chee M. Ng Breakdown of academic impact, for papers by Rajeev Menon Breakdown of academic impact, for papers by Akintunde Bello Breakdown of academic impact, for papers by E. Brendel Breakdown of academic impact, for papers by Jiang Liu
Rankless by CCL
2026